You can buy or sell Bellus Health and other stocks, options, and ETFs commission-free!
BELLUS Health Inc. Common Shares, also called Bellus Health, is a biopharmaceutical development company which engages in the research and development of novel therapeutics for the treatment of chronic cough and other hypersensitisation disorders. Its product, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. The listed name for BLU is BELLUS Health Inc. Common Shares.
52 Week High
52 Week Low
— per share
-$0.09 per share